Literature DB >> 6894266

Studies on heart. XIX. Isolation of an atrial peptide that improves the rhythmicity of cultured myocardial cell clusters.

S Aonuma, Y Kohama, K Akai, Y Komiyama, S Nakajima, M Wakabayashi, T Makino.   

Abstract

Mesh：

Substances：

Year:  1980        PMID： 6894266     DOI： 10.1248/cpb.28.3332

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN： 0009-2363            Impact factor:   1.645


× No keyword cloud information.
  13 in total

Review 1.  Dysregulation of cell adhesion proteins and cardiac arrhythmogenesis.

Authors:  Jifen Li; Vickas V Patel; Glenn L Radice
Journal:  Clin Med Res       Date:  2006-03

Review 2.  Improving cardiac gap junction communication as a new antiarrhythmic mechanism: the action of antiarrhythmic peptides.

Authors:  Stefan Dhein; Anja Hagen; Joanna Jozwiak; Anna Dietze; Jens Garbade; Markus Barten; Martin Kostelka; Friedrich-Wilhelm Mohr
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-11-27       Impact factor: 3.000

Review 3.  Increasing gap junctional coupling: a tool for dissecting the role of gap junctions.

Authors:  Lene Nygaard Axelsen; Ketil Haugan; Martin Stahlhut; Anne-Louise Kjølbye; James K Hennan; Niels-Henrik Holstein-Rathlou; Jørgen Søberg Petersen; Morten Schak Nielsen
Journal:  J Membr Biol       Date:  2007-06-14       Impact factor: 1.843

Review 4.  Therapeutic potential of antiarrhythmic peptides. Cellular coupling as a new antiarrhythmic target.

Authors:  S Dhein; T Tudyka
Journal:  Drugs       Date:  1995-06       Impact factor: 9.546

5.  Antiarrhythmic peptide has no direct cardiac actions.

Authors:  T Argentieri; E Cantor; J R Wiggins
Journal:  Experientia       Date:  1989-08-15

Review 6.  Cardiac to cancer: connecting connexins to clinical opportunity.

Authors:  Christina L Grek; J Matthew Rhett; Gautam S Ghatnekar
Journal:  FEBS Lett       Date:  2014-03-04       Impact factor: 4.124

Review 7.  Pharmacological modulation of connexin-formed channels in cardiac pathophysiology.

Authors:  Elke De Vuyst; Kerstin Boengler; Gudrun Antoons; Karin R Sipido; Rainer Schulz; Luc Leybaert
Journal:  Br J Pharmacol       Date:  2011-06       Impact factor: 8.739

Review 8.  Connexins in Cardiovascular and Neurovascular Health and Disease: Pharmacological Implications.

Authors:  Luc Leybaert; Paul D Lampe; Stefan Dhein; Brenda R Kwak; Peter Ferdinandy; Eric C Beyer; Dale W Laird; Christian C Naus; Colin R Green; Rainer Schulz
Journal:  Pharmacol Rev       Date:  2017-10       Impact factor: 25.468

9.  A new synthetic antiarrhythmic peptide reduces dispersion of epicardial activation recovery interval and diminishes alterations of epicardial activation patterns induced by regional ischemia. A mapping study.

Authors:  S Dhein; N Manicone; A Müller; R Gerwin; U Ziskoven; A Irankhahi; C Minke; W Klaus
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-08       Impact factor: 3.000

Review 10.  New drugs for atrial fibrillation.

Authors:  Matthias Hammwöhner; Jan Smid; Uwe Lendeckel; Andreas Goette
Journal:  J Interv Card Electrophysiol       Date:  2008-06-06       Impact factor: 1.900
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.